Brookemont Evaluating Agriculture, Medical, Pharmaceutical, Resources and Real Estate Opportunities
March 24 2014 - 3:01AM
Marketwired
Brookemont Evaluating Agriculture, Medical, Pharmaceutical,
Resources and Real Estate Opportunities
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Mar 24, 2014) -
Brookemont Capital Inc. ("BKT", "Brookemont" or the "Company")
(TSX-VENTURE:BKT)(PINKSHEETS:BKTPF)(FRANKFURT:BRO) wishes to
announce that management will be actively pursuing additional
corporate growth drivers. The new areas that will be investigated
will potentially include, but will not be limited to, agriculture,
medical, pharmaceutical, resources and real estate. At this time no
new project has been contemplated and there is no guarantee that
one will be completed.
Conrad Clemiss, president of Brookemont states, "We are
constantly looking for projects that may increase shareholder
value, and given the recent excitement generated within specific
sectors such as medical marihuana, we would be not doing our job as
if we did not look into a variety of projects that may help build
BKT's assets."
Brookemont has several ongoing projects including: a) a 100%
interest in the "Albany East" Prospect. This land is prospective
for hydrothermal (vein) graphite and directly borders Zenyatta
Ventures Ltd. property that hosts its hydrothermal graphite
deposit; b) a 100-per-cent interest in the Kenagami hydrothermal
graphite prospect in Ontario; and c) an aluminous clay and rare
earth prospect in the Gaspe Bay Region of Quebec, which directly
borders the Grand-Vallée Deposit of Orbite Aluminae Inc.
If you would like to be added the BKT email list please send an
email to brookemontinfo@gmail.com.
Neither the TSX Venture Exchange Inc. nor its Regulation Service
Provider (as that term is defined in the policies of the TSX
Venture Exchange Inc.) accepts responsibility for the adequacy or
accuracy of this press release.
Brookemont Capital Inc.Conrad ClemissPresident, Director1 604
899-9150brookemontinfo@gmail.comwww.Brookemontcapital.com